Effect of prebiotics on biomarkers of colorectal cancer in humans: A systematic review

Department of Food Science and Nutrition, University of Minnesota, Saint Paul, Minnesota 55108, USA.
Nutrition Reviews (Impact Factor: 6.08). 08/2012; 70(8):436-43. DOI: 10.1111/j.1753-4887.2012.00495.x
Source: PubMed


Prebiotics may prevent colorectal cancer (CRC) development in humans by modifying the composition or activity of the colorectal microflora. Epidemiologic and animal studies have shown a reduction in CRC or CRC biomarkers after the administration of prebiotics. Studies using indirect chemical biomarkers of CRC in humans, however, gave mixed results. Recently, human studies measuring direct physical indices of CRC risk after prebiotic consumption have been published. The purpose of this review is to summarize those studies to provide recommendations for the use of prebiotics in CRC risk reduction. A PubMed search was conducted, revealing nine studies. One tested lactulose, two evaluated a blend of oligofructose and inulin, and six measured resistant starch. Lactulose reduced adenoma recurrence, while resistant starch had no effect on adenoma or CRC development. Crypt mitotic location, gene expression, and DNA methylation were somewhat improved after resistant starch consumption. No changes in cell proliferation and apoptosis, crypt morphology, or aberrant crypt foci were found. More human studies measuring physical changes to the gut are needed.

Download full-text


Available from: Joanne Slavin, May 21, 2015
  • Source
    • "Inulin, the main commercial fructan polymer, consists of a linear chain of beta 2-1 linked fructosyl units with a single terminal glucose. Inulin is used by the food industry as fat replacer (Arcia et al. 2011; Nowak et al. 2007) or low calories sweetener depending on the length of inulin molecules , while the pharmaceutical industry exploits its health promoting properties (Clark et al. 2012; Closa-Monasterolo et al. 2013; Di Bartolomeo et al. 2013). Average inulin polymerization degree (DP) varies between species, but also according to developmental stage and environmental conditions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Key message Nucleotidic polymorphisms were identified in fructan exohydrolases genes which are statistically associated with enhanced susceptibility to post-harvest inulin depolymerization. Abstract Industrial chicory (Cichorium intybus L.) root is the main commercial source of inulin, a linear fructose polymer used as dietary fiber. Post-harvest, inulin is depolymerized into fructose which drastically increases processing cost. To identify genetic variations associated with enhanced susceptibility to post-harvest inulin depolymerization and related free sugars content increase, we used a candidate-gene approach focused on inulin and sucrose synthesis and degradation genes, all members of the family 32 of glycoside hydrolases (GH32). Polymorphism in these genes was first investigated by carrying out EcoTILLING on two groups of chicory breeding lines exhibiting contrasted response to post-harvest inulin depolymerization. This allowed the identification of polymorphisms significantly associated with depolymerization in three fructan exohydrolase genes (FEH). This association was confirmed on a wider panel of 116 unrelated families in which the FEH polymorphism explained 35 % of the post-harvest variance for inulin content, 36 % of variance for sucrose content, 18 % for inulin degree of polymerization, 23 % for free fructose content and 22 % for free glucose content. These polymorphisms were associated with significant post-harvest changes of inulin content, inulin chain length and free sugars content.
    Theoretical and Applied Genetics 10/2013; 127(1). DOI:10.1007/s00122-013-2206-6 · 3.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer (CRC) is the third most common form of human cancer. Diverse therapies such as surgery and chemotherapy have shown excellent results in CRC. However, they still have limitations. There is a need to develop new CRC treatment strategies. Probiotic formulations have shown excellent promises in CRC as modest, preventive and early stage therapeutics. This review summarizes the recent development of probiotics in CRC and highlights the importance of the intestinal microbiota balance in CRC, cover current research on probiotics for CRC prevention and treatment with emphasis on the mechanisms involved. Specifically, this report describes evidences on the role of probiotics in inhibiting tumor progression, in reducing oxidative stress, in reducing colon cell DNA damage, in producing anti-cancer compounds, in improving the microflora balance, in stimulating the host immune response and in other physiochemical conditions of the gut. Even though, some of these effects were observed in several human trials when probiotics formulations were used as a supplement with CRC therapies, the application of probiotics as a biotherapeutic against CRC still needs further investigations.
    Journal of Medical Microbiology 04/2013; 62(Pt_8). DOI:10.1099/jmm.0.048975-0 · 2.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study investigated if additional non-starch polysaccharide (NSP) or resistant starch (RS), above that currently recommended, leads to better improvement in insulin sensitivity (IS) than observed with modest weight loss (WL). Obese male volunteers (n = 14) were given an energy-maintenance (M) diet containing 27 g NSP and 5 g RS daily for one week. They then received, in a cross-over design, energy-maintenance intakes of either an NSP-enriched diet (42 g NSP, 2.5 g RS) or an RS-enriched diet (16 g NSP, 25 g RS), each for three weeks. Finally, a high protein (30% calories) WL diet was provided at 8 MJ/day for three weeks. During each dietary intervention, endogenous glucose production (EGP) and IS were assessed. Fasting glycaemia was unaltered by diet, but plasma insulin and C-peptide both decreased with the WL diet (p < 0.001), as did EGP (-11%, p = 0.006). Homeostatis model assessment of insulin resistance improved following both WL (p < 0.001) and RS (p < 0.05) diets. Peripheral tissue IS improved only with WL (57%-83%, p < 0.005). Inclusion of additional RS or NSP above amounts currently recommended resulted in little or no improvement in glycaemic control, whereas moderate WL (approximately 3 kg fat) improved IS.
    Nutrients 06/2013; 5(6):2144-72. DOI:10.3390/nu5062144 · 3.27 Impact Factor
Show more